Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

This study has been completed.

First Received on September 20, 1999. Last Updated on August 11, 2008 History of Changes

Sponsor:	National Institute on Drug Abuse (NIDA)
Collaborator:	University of Texas
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000307

Purpose

The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.

Condition	Intervention	Phase
Alcohol-Related Disorders Cocaine-Related Disorders	Drug: Naltrexone	Phase II

Study Type:	Interventional
Study Design:	Primary Purpose: Treatment
Official Title:	Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients

Resource links provided by NLM:

Drug Information available for: Cocaine hydrochloride Naltrexone Naltrexone hydrochloride

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Verified abstinence from cocaine [ Time Frame: over the 12 weeks of study ] [ Designated as safety issue: No ]

Estimated Enrollment:	0
Study Start Date:	April 2003
Study Completion Date:	April 2007
Primary Completion Date:	April 2007 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years to 50 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000307

Locations

United States, Texas
University of Texas Health Science Center
Houston, Texas, United States, 77225

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Texas

Investigators

Principal Investigator:

John Grabowski, Ph.D.

University of Texas

More Information

No publications provided

Responsible Party:	Joy Schmitz, Ph.D., University of Texas Medical School at Houston
ClinicalTrials.gov Identifier:	NCT00000307 History of Changes
Other Study ID Numbers:	NIDA-09262-4, P50-09262-4
Study First Received:	September 20, 1999
Last Updated:	August 11, 2008
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Alcohol-Related Disorders
Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders
Naltrexone
Narcotic Antagonists

Physiological Effects of Drugs
Pharmacologic Actions
Sensory System Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on February 12, 2012